SanBio Company Limited – Trademark Portfolio
Entity Type: 03
SanBio Company Limited holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 6 trademarks are registered and 4 are pending. Notable registered marks include AKUUGO, SANSTEMZA, ZELLBRIDGE, AKUUGO VANDEFITEMCEL, and SANSTEMZA VANDEFITEMCEL.
8-1, Akashi-Cho
Chuo-Ku Tokyo 104-0044
Showing of trademarks Trademarks
Trademark Classifications
SanBio Company Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SanBio Company Limited have?
SanBio Company Limited has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 pending.
What trademark classes does SanBio Company Limited file in?
SanBio Company Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SanBio Company Limited's most well-known trademarks?
SanBio Company Limited's registered trademark portfolio includes well-known marks such as AKUUGO, SANSTEMZA, ZELLBRIDGE, AKUUGO VANDEFITEMCEL, and SANSTEMZA VANDEFITEMCEL. These are among 6 currently registered trademarks in the portfolio.
What is SanBio Company Limited's trademark registration success rate?
SanBio Company Limited has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 4 applications are pending review.